Literature DB >> 27423978

The state and consequences of dermatology drug prices in the United States.

Joerg Albrecht1, Mark Lebwohl2, Maryam M Asgari3, Daniel D Bennett4, Ashley Cook5, Colby C Evans6, Lawrence J Green7, Julie A Hodge8, Arianne S Kourosh3, Mary E Maloney9, Leah M Howard10, Elise A Olsen11, Steven P Rosenberg12, Adam Rubin13, Dow B Stough14, Susan C Taylor13, Bruce Alan Brod15.   

Abstract

Keywords:  coinsurances; drug pricing; formulary tiering; generic drugs; out-of-pocket costs; pharmacy benefit managers; prior authorizations

Mesh：

Substances：

Year:  2016        PMID： 27423978     DOI： 10.1016/j.jaad.2016.03.053

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

1.  Evaluating the effect of prior authorizations in patients with complex dermatologic conditions.

Authors:  Olivia S Jew; Joyce Okawa; John S Barbieri; Joanne McCaffrey; Elizabeth Hayward; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2020-07-02       Impact factor: 11.527
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.